Cargando…
Efficacy and safety of anti-hepatic fibrosis drugs
Recent progress in our understanding of the pathways linked to progression from hepatic insult to cirrhosis has led to numerous novel therapies being investigated as potential cures and inhibitors of hepatic fibrogenesis. Liver cirrhosis is the final result of prolonged fibrosis, which is an intimat...
Autores principales: | Damiris, Konstantinos, Tafesh, Zaid H, Pyrsopoulos, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656211/ https://www.ncbi.nlm.nih.gov/pubmed/33244194 http://dx.doi.org/10.3748/wjg.v26.i41.6304 |
Ejemplares similares
-
Hepatitis E in immunocompromised individuals
por: Damiris, Konstantinos, et al.
Publicado: (2022) -
Cellular based treatment modalities for unresectable hepatocellular carcinoma
por: Damiris, Konstantinos, et al.
Publicado: (2021) -
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
por: Han, Ma Ai Thanda, et al.
Publicado: (2021) -
Trends in hospitalization for alcoholic hepatitis from 2011 to 2017: A USA nationwide study
por: Wakil, Ali, et al.
Publicado: (2022) -
Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021)